Health

Editas Medicine Inc (NASDAQ:EDIT) Reports USPTO Decision Positive To Broad Institute In CRISPR Intervention
Health Technology

Editas Medicine Inc (NASDAQ:EDIT) Reports USPTO Decision Positive To Broad Institute In CRISPR Intervention

Editas Medicine Inc (NASDAQ:EDIT) reported that the USPTO released a favorable verdict in the CRISPR intervention between the University of Vienna, the University of California, the Broad Institute, Inc. and Emmanuelle Charpentier pertaining specific CRISPR-Cas9 patents the firm solely licenses from Broad. The USPTO approved Broad’s objective for “No Interference […]

Reliv International, Inc (NASDAQ:RELV) CardioSentials Heart Health Supplement Gets Patent
Health

Reliv International, Inc (NASDAQ:RELV) CardioSentials Heart Health Supplement Gets Patent

Reliv International, Inc (NASDAQ:RELV) reported that CardioSentials® heart health supplement has obtained a U.S. patent. The company first shared the success with the firm’s distributors through a podcast showcasing Dr. Carl Hastings, the Chief Scientific Officer and also the product’s creator. The details CardioSentials’ patented formula comprises ingredients demonstrated to […]

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics
Health

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) Updates On Commercialization Of CBD Personalized Diagnostics

Cannabics Pharmaceuticals Inc (OTCMKTS:CNBX) will launch personalized CBD anti-tumor tests for people suffering with cancer. The diagnostic tests use liquid biopsies of cancer patients. It uses CTC technology that accumulates cancer cells from cancer patients’ blood samples, and assesses their sensitivity to CBD compounds together with conventional chemotherapy drug. The […]